Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 19/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6613178 | 0.88 | CCR5 (0.60) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6610898 | 0.88 | CCR5 (0.54) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6615476 | 0.86 | CCR5 (0.56) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6616956 | 0.86 | CCR5 (0.59) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6613427 | 0.84 | CCR5 (0.54) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6615639 | 0.83 | CCR5 (0.59) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6613555 | 0.83 | CCR5 (0.58) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6613731 | 0.81 | CCR5 (0.59) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6612023 | 0.81 | CCR5 (0.68) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6614484 | 0.80 | CCR5 (0.54) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7119091-B2 | Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-10-10 | — | — | US | disclosed |
| EP-1236726-B1 | TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2004-12-01 | — | — | EP | disclosed |
| EP-1236726-A1 | TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-09-04 | — | — | EP | disclosed |